[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

Know your GDPs and your “ Vs” “Us” and “Ws”

by Jackie (née Heneghan) Peck | Sep 10, 2020 | Blog

In the past, the MHRA has told a pharmaceutical wholesaler to find a new Responsible Person when they did not know the correct definition for “GDP” in their MHRA inspection. The RP used the “ Gross Domestic Product “ definition to his peril…

Vaccines (Covid-19)

Vaccines (Covid-19)

by Jackie (née Heneghan) Peck | Sep 10, 2020 | Blog

Vaccines are critical to public health as they prevent disease and curb community transmission…

What will happen to EU Imports after the Transition Period ends?

by Jackie (née Heneghan) Peck | Aug 14, 2020 | Blog, Brexit

EU goods imported into Great Britain after the Transition Period has ended will be subject to new UK Border controls which will be introduced in stages. This should give businesses affected by coronavirus a little more time to prepare. New border control post will be built and monies have been set aside to help fund the changes required and stakeholders…

Next Steps in the NHS Phase 3 planning

Next Steps in the NHS Phase 3 planning

by Jackie (née Heneghan) Peck | Aug 14, 2020 | Blog

he NHS has announced their Phase 3 planning and will be working on restoring adult and older people’s health services in the community…

The British Journal of Clinical Pharmacology has issued guidance on risks of taking alternative therapies and warfarin

The British Journal of Clinical Pharmacology has issued guidance on risks of taking alternative therapies and warfarin

by Jackie (née Heneghan) Peck | Jul 20, 2020 | Blog

Pharmacy and healthcare staff should be aware and ask patients if they take any other medication when prescribing…

« Older Entries
Next Entries »

Recent Posts

  • Journalists – Be Careful What You Write About Medicines
  • Responsible Person for Import Role after the Windsor Framework
  • Emerging Risks in Pharmacy Practice: Key Updates from the GPhC

Upcoming Courses

  • GDP/RP Cogent Gold Standard Online Training on 20 May 2025
  • Introduction to Good Distribution Practice Online Training on 28 May 2025 10:00 am
  • Licence Holder Training on 10 June 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 17 June 2025
  • RP Forum – Inspection Preparation and RP Readiness on 8 July 2025 10:00 am

MHRA Alerts & Recalls

Field Safety Notices: 5 to 9 May 2025
14 May 2025
Class 4 Medicines Notification, Chemidex Pharma Ltd, Various Products, EL(25)A/21
13 May 2025
Field Safety Notices: 28 October to 1 November 2024
8 May 2025
Class 4 Medicines Defect Notification: Chloramphenicol 1% w/w Eye Ointment, Blumont Pharma Limited, EL(25)A/20
8 May 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow